TY - BOOK AU - Manzoor, Saira AU - Supervisor : Dr. Muhammad Nabeel Anwar TI - Enhancing the Functionality of Polyethersulfone Hemodialysis Membranes Using Water-Soluble Hydrophilic Additives U1 - 610 PY - 2024/// CY - Islamabad : PB - SMME- NUST; KW - MS Biomedical Sciences (BMS) N1 - The kidneys play a critical part in maintaining internal equilibrium of the body. However, renal diseases present a significant public health concern, affecting millions of individuals worldwide. Polyethersulfone (PES) based hemodialysis membranes can provide a lifesustaining treatment procedure for patients suffering from renal disease. Nevertheless, the intrinsic hydrophobic nature of PES contributes to an inefficiency of uremic toxin clearance and a compromised hemocompatibility. This work evaluates the individual and combined effects of two water-soluble hydrophilic additives, polyethylene glycol (PEG) and polyvinylpyrrolidone (PVP), on the functionality of polyethersulfone (PES) membranes. The membranes were synthesized by the non-solvent phase inversion method by using NMP as the solvent. The fabricated membranes were characterized by using Scanning Electron Microscopy, ATR-FTIR, tensile testing, porosity, and contact angle analysis. The SEM images demonstrated the successful fabrication of the membranes. Each membrane possessed a thin skin layer and an asymmetric porous framework. As a result of the synergistic effect, the membrane with dual WSP—2.5% PVP and 2.5% PEG— performed better than membranes with a single water-soluble hydrophilic additive. The membranes comprising the two additives had excellent hydrophilicity, increased porosity, and a high-water retention capacity. Moreover, they showed a urea clearance of 77.3%, a pure water flux of 96 L/m²/h, and an outstanding BSA rejection of 99.10%. RSM modelling was employed to determine the urea clearance that verified the ideal conditions for urea removal were concentrations of 1200 mg/L and 0.6 MPa. The effectiveness of membrane containing dual WSP for hemodialysis was further demonstrated by hemocompatibility xv tests, which provided promising results (APTT 32s, PT 14s, plasma recalcification time 205.5s, and hemolysis rate 1.32%). UR - http://10.250.8.41:8080/xmlui/handle/123456789/42792 ER -